目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Services
1.1.2. End-user
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2

Chapter 2. Executive Summary
2.1. Market Outlook

Chapter 3. Biomarker Testing Services Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.1.1. Increasing demand for biomarker testing for cancer detection
3.3.1.2. Increasing R&D activities
3.3.1.3. Growing burden of chronic and infectious diseases supporting demand for biomarker testing
3.3.2. Market restraint analysis
3.3.2.1. High capital investments and lengthy timelines for biomarker development
3.4. Biomarker Testing Services Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.2. PESTEL Analysis
3.4.3. Major Deals & Strategic Alliances Analysis
3.4.3.1. Mergers and Acquisition
3.4.3.2. Expansions
3.4.3.3. Agreements and Collaborations
3.4.3.4. Product and Service Launches
3.5. Covid-19 Impact and Reformation Strategy

Chapter 4. Biomarker Testing Services Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.2. Biomarker Testing Services Market Share, 2021 & 2030
4.2.1. Biomarker Assay Development & Validation
4.2.1.1. Biomarker assay development & validation market estimates and forecast 2018 to 2030 (USD Billion)
4.2.2. Flow cytometry
4.2.2.1. Flow cytometry market estimates and forecast 2018 to 2030 (USD Billion)
4.2.3. Others
4.2.3.1. Others market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 5. Biomarker Testing Services Market: End-user Estimates & Trend Analysis
5.1. Definitions and Scope
5.2. Biomarker Testing Services Market Share, 2021 & 2030
5.2.1. Pharmaceutical and biotechnology companies
5.2.1.1. Pharmaceutical and biotechnology companies market estimates and forecast 2018 to 2030 (USD Billion)
5.2.2. Research Institutes
5.2.2.1. Research Institutes market estimates and forecast 2018 to 2030 (USD Billion)
5.2.3. CROS
5.2.3.1. CROS market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 6. Biomarker Testing Services Market: Regional Estimates & Trend Analysis
6.1. Regional market share analysis, 2021& 2030
6.2. North America
6.2.1. U.S.
6.2.1.1. U.S. Market estimates and forecast, 2018 - 2030
6.2.2. Canada
6.2.2.1. Canada Market estimates and forecast, 2018 - 2030
6.3. Europe
6.3.1. U.K.
6.3.1.1. U.K. Market estimates and forecast, 2018 - 2030
6.3.2. Germany
6.3.2.1. Germany Market estimates and forecast, 2018 - 2030
6.3.3. France
6.3.3.1. France Market estimates and forecast, 2018 - 2030
6.3.4. Italy
6.3.4.1. Italy Market estimates and forecast, 2018 - 2030
6.3.5. Spain
6.3.5.1. Spain Market estimates and forecast, 2018 - 2030
6.3.6. Netherlands
6.3.6.1. Netherlands Market estimates and forecast, 2018 - 2030
6.3.7. Sweden
6.3.7.1. Sweden Market estimates and forecast, 2018 - 2030
6.3.8. Switzerland
6.3.8.1. Switzerland Market estimates and forecast, 2018 - 2030
6.4. Asia Pacific
6.4.1. Japan
6.4.1.1. Japan Market estimates and forecast, 2018 - 2030
6.4.2. China
6.4.2.1. China Market estimates and forecast, 2018 - 2030
6.4.3. India
6.4.3.1. India Market estimates and forecast, 2018 - 2030
6.4.4. Australia
6.4.4.1. Australia Market estimates and forecast, 2018 - 2030
6.4.5. South Korea
6.4.5.1. South Korea Market estimates and forecast, 2018 - 2030
6.4.6. Thailand
6.4.6.1. Thailand Market estimates and forecast, 2018 - 2030
6.4.7. Malaysia
6.4.7.1. Malaysia Market estimates and forecast, 2018 - 2030
6.4.8. Indonesia
6.4.8.1. New Zealand Market estimates and forecast, 2018 - 2030
6.4.9. Taiwan
6.4.9.1. Philippines Market estimates and forecast, 2018 - 2030
6.4.10. Singapore
6.4.10.1. Singapore Market estimates and forecast, 2018 - 2030
6.5. Latin America
6.5.1. Brazil
6.5.1.1. Brazil Market estimates and forecast, 2018 - 2030
6.5.2. Mexico
6.5.2.1. Mexico Market estimates and forecast, 2018 - 2030
6.5.3. Argentina
6.5.3.1. Argentina Market estimates and forecast, 2018 - 2030
6.5.4. Colombia;
6.5.4.1. Colombia Market estimates and forecast, 2018 - 2030
6.6. MEA
6.6.1. South Africa
6.6.1.1. South Africa Market estimates and forecast, 2018 - 2030
6.6.2. Saudi Arabia
6.6.2.1. Saudi Arabia Market estimates and forecast, 2018 - 2030
6.6.3. UAE
6.6.3.1. UAE Market estimates and forecast, 2018 - 2030
6.6.4. Israel
6.6.4.1. Israel Market estimates and forecast, 2018 - 2030

Chapter 7. Competitive Analysis
7.1. Recent Developments & Impact Analysis, By Key Market Participant
7.2. Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
7.3. Participant Categorization
7.4. Vendor Landscape
7.4.1. List of Key Service Providers
7.4.2. Market Differentiators
7.4.3. Biomarker Testing Services Market Share Analysis

Chapter 8. Competitive Landscape
8.1. Company Profiles
8.1.1. Bio Agilytix Labs
8.1.1.1. Company overview
8.1.1.2. Service Benchmarking
8.1.1.3. Strategic initiatives
8.1.2. Eurofins Scientific
8.1.2.1. Company overview
8.1.2.2. Financial performance
8.1.2.3. Service Benchmarking
8.1.2.4. Strategic initiatives
8.1.3. SGS SA
8.1.3.1. Company overview
8.1.3.2. Financial performance
8.1.3.3. Service Benchmarking
8.1.3.4. Strategic initiatives
8.1.4. Charles River Laboratories
8.1.4.1. Company overview
8.1.4.2. Financial performance
8.1.4.3. Service Benchmarking
8.1.4.4. Strategic initiatives
8.1.5. Laboratory Corporation of America Holding
8.1.5.1. Company overview
8.1.5.2. Financial performance
8.1.5.3. Service Benchmarking
8.1.5.4. Strategic initiatives
8.1.6. Thermo Fisher Scientific, Inc. (PPD, Inc.)
8.1.6.1. Company overview
8.1.6.2. Financial performance
8.1.6.3. Service Benchmarking
8.1.6.4. Strategic initiatives
8.1.7. ICON Plc
8.1.7.1. Company overview
8.1.7.2. Financial performance
8.1.7.3. Service Benchmarking
8.1.7.4. Strategic initiatives
8.1.8. IQVIA, Inc.
8.1.8.1. Company overview
8.1.8.2. Financial performance
8.1.8.3. Service Benchmarking
8.1.8.4. Strategic initiatives
8.1.9. Syneos Health
8.1.9.1. Company overview
8.1.9.2. Financial performance
8.1.9.3. Service Benchmarking
8.1.9.4. Strategic initiatives
8.1.10. Intertek Group Plc
8.1.10.1. Company overview
8.1.10.2. Financial performance
8.1.10.3. Service Benchmarking
8.1.10.4. Strategic initiatives

List of Tables
Table 1 List of secondary sources
Table 2 List of Abbreviations

List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value - chain - based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity flow analysis
Fig. 9 Volume Price Analysis
Fig. 10 Biomarker Testing Services market snapshot (2021)
Fig. 11 Biomarker Testing Services market segmentation
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Market restraint relevance analysis (Current & future impact)
Fig. 14 Penetration & growth prospect mapping
Fig. 15 Porter’s five forces analysis
Fig. 16 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 17 Biomarker Testing Services market service outlook: Segment dashboard
Fig. 18 Biomarker Testing Services market: Service movement analysis
Fig. 19 Biomarker Assay Development & Validation market (USD Million)
Fig. 20 Flow cytometry market (USD Million)
Fig. 21 Others market (USD Million)
Fig. 22 Biomarker Testing Services market End - user outlook: Segment dashboard
Fig. 23 Biomarker Testing Services market: End - user movement analysis
Fig. 24 Pharmaceutical and biotechnology companies market (USD Million)
Fig. 25 Research Institutes market (USD Million)
Fig. 26 CROs market (USD Million)
Fig. 27 Regional market: Key takeaways
Fig. 28 Regional outlook, 2021 & 2030
Fig. 29 North America market, 2018 - 2030 (USD Million)
Fig. 30 U.S. market, 2018 - 2030 (USD Million)
Fig. 31 Canada Market, 2018 - 2030 (USD Million)
Fig. 32 Europe Market, 2018 - 2030 (USD Million)
Fig. 33 U.K Market, 2018 - 2030 (USD Million)
Fig. 34 Germany Market, 2018 - 2030 (USD Million)
Fig. 35 France Market, 2018 - 2030 (USD Million)
Fig. 36 Italy Market, 2018 - 2030 (USD Million)
Fig. 37 Spain Market, 2018 - 2030 (USD Million)
Fig. 38 Netherlands Market, 2018 - 2030 (USD Million)
Fig. 39 Switzerland Market, 2018 - 2030 (USD Million)
Fig. 40 Sweden Market, By Service, 2018 - 2030 (USD Million)
Fig. 41 Asia Pacific market, 2018 - 2030 (USD Million)
Fig. 42 China market, 2018 - 2030 (USD Million)
Fig. 43 India market, 2018 - 2030 (USD Million)
Fig. 44 Japan market, 2018 - 2030 (USD Million)
Fig. 45 Australia market, 2018 - 2030 (USD Million)
Fig. 46 Malaysia market, 2018 - 2030 (USD Million)
Fig. 47 Indonesia market, 2018 - 2030 (USD Million)
Fig. 48 Taiwan market, 2018 - 2030 (USD Million)
Fig. 49 Thailand market, 2018 - 2030 (USD Million)
Fig. 50 Singapore market, 2018 - 2030 (USD Million)
Fig. 51 South Korea market, 2018 - 2030 (USD Million)
Fig. 52 Latin America market, 2018 - 2030 (USD Million)
Fig. 53 Brazil market, 2018 - 2030 (USD Million)
Fig. 54 Mexico market, 2018 - 2030 (USD Million)
Fig. 55 Argentina market, 2018 - 2030 (USD Million)
Fig. 56 Colombia market, 2018 - 2030 (USD Million)
Fig. 57 MEA market, 2018 - 2030 (USD Million)
Fig. 58 South Africa market, 2018 - 2030 (USD Million)
Fig. 59 Saudi Arabia market, 2018 - 2030 (USD Million)
Fig. 60 Israel market, 2018 - 2030 (USD Million)
Fig. 61 UAE market, 2018 - 2030 (USD Million)